Evidence map›Paper›PMID 39292644›Full record

ArticlePloS one2024

A systematic evaluation of the performance and properties of the UK Biobank Polygenic Risk Score (PRS) Release.

Deborah J Thompson, Daniel Wells, Saskia Selzam, Iliana Peneva, Rachel Moore, Kevin Sharp, William A Tarran, Edward J Beard, Fernando Riveros-Mckay, Carla Giner-Delgado and 9 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Metabolic syndrome is associated with accelerated brain aging.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  18. Article
  19. Article
  20. Article

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Deborah J ThompsonGenomics plc, Oxford, United Kingdom.ORCID https://orcid.org/0000-0003-1465-5799
Daniel WellsGenomics plc, Oxford, United Kingdom.ORCID https://orcid.org/0000-0002-2007-8978
Saskia SelzamGenomics plc, Oxford, United Kingdom.
Iliana PenevaGenomics plc, Oxford, United Kingdom.
Rachel MooreGenomics plc, Oxford, United Kingdom.
Kevin SharpGenomics plc, Oxford, United Kingdom.
William A TarranGenomics plc, Oxford, United Kingdom.
Edward J BeardGenomics plc, Oxford, United Kingdom.
Fernando Riveros-MckayGenomics plc, Oxford, United Kingdom.
Carla Giner-DelgadoGenomics plc, Oxford, United Kingdom.
Duncan PalmerGenomics plc, Oxford, United Kingdom.
Priyanka SethGenomics plc, Oxford, United Kingdom.
James HarrisonGenomics plc, Oxford, United Kingdom.
Marta FutemaCardiology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, United Kingdom.
Genomics England Research Consortium
Gil McVeanGenomics plc, Oxford, United Kingdom.
Vincent PlagnolGenomics plc, Oxford, United Kingdom.
Peter DonnellyGenomics plc, Oxford, United Kingdom.
Michael E WealeGenomics plc, Oxford, United Kingdom.ORCID https://orcid.org/0000-0003-4593-1186

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We assess the UK Biobank (UKB) Polygenic Risk Score (PRS) Release, a set of PRSs for 28 diseases and 25 quantitative traits that has been made available on the individuals in UKB, using a unified pipeline for PRS evaluation. We also release a benchmarking software tool to enable like-for-like performance evaluation for different PRSs for the same disease or trait. Extensive benchmarking shows the PRSs in the UKB Release to outperform a broad set of 76 published PRSs. For many of the diseases and traits we also validate the PRS algorithms in a separate cohort (100,000 Genomes Project). The availability of PRSs for 53 traits on the same set of individuals also allows a systematic assessment of their properties, and the increased power of these PRSs increases the evidence for their potential clinical benefit.

Indexed as

Genetic Predisposition to DiseaseMultifactorial InheritanceAlgorithmsBenchmarkingBiological Specimen BanksGenetic Risk ScoreGenome-Wide Association StudyHumansRisk FactorsSoftwareUK BiobankUnited Kingdom

Identifiers

PMID39292644
PMCPMC11410272

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.